ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:AQNB • US0158578080

25.91 USD
+0.1 (+0.39%)
Last: Feb 6, 2026, 08:18 PM
Fundamental Rating

3

Taking everything into account, AQNB scores 3 out of 10 in our fundamental rating. AQNB was compared to 26 industry peers in the Multi-Utilities industry. While AQNB seems to be doing ok healthwise, there are quite some concerns on its profitability. AQNB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year AQNB was profitable.
  • In the past year AQNB had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: AQNB reported negative net income in multiple years.
  • AQNB had a positive operating cash flow in each of the past 5 years.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

  • AQNB has a Return On Assets of -0.27%. This is amonst the worse of the industry: AQNB underperforms 96.15% of its industry peers.
  • Looking at the Return On Equity, with a value of -0.80%, AQNB is doing worse than 96.15% of the companies in the same industry.
  • AQNB has a worse Return On Invested Capital (3.16%) than 88.46% of its industry peers.
  • AQNB had an Average Return On Invested Capital over the past 3 years of 2.36%. This is in line with the industry average of 3.95%.
  • The 3 year average ROIC (2.36%) for AQNB is below the current ROIC(3.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROIC 3.16%
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • Looking at the Operating Margin, with a value of 21.55%, AQNB is in line with its industry, outperforming 53.85% of the companies in the same industry.
  • In the last couple of years the Operating Margin of AQNB has declined.
  • With a decent Gross Margin value of 73.94%, AQNB is doing good in the industry, outperforming 73.08% of the companies in the same industry.
  • AQNB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.55%
PM (TTM) N/A
GM 73.94%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AQNB is destroying value.
  • Compared to 1 year ago, AQNB has more shares outstanding
  • AQNB has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for AQNB has been reduced compared to a year ago.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.32, we must say that AQNB is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of AQNB (1.32) is better than 96.15% of its industry peers.
  • AQNB has a Debt/Equity ratio of 1.33. This is a high value indicating a heavy dependency on external financing.
  • With a decent Debt to Equity ratio value of 1.33, AQNB is doing good in the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACC0.45
WACC7.05%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

  • AQNB has a Current Ratio of 1.23. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
  • AQNB's Current ratio of 1.23 is amongst the best of the industry. AQNB outperforms 88.46% of its industry peers.
  • AQNB has a Quick Ratio of 1.03. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
  • AQNB has a Quick ratio of 1.03. This is amongst the best in the industry. AQNB outperforms 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.03
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

  • The earnings per share for AQNB have decreased strongly by -29.79% in the last year.
  • Measured over the past years, AQNB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.38% on average per year.
  • The Revenue for AQNB has decreased by -23.92% in the past year. This is quite bad
  • The Revenue has been growing slightly by 7.38% on average over the past years.
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.09% on average over the next years.
  • Based on estimates for the next years, AQNB will show a small growth in Revenue. The Revenue will grow by 2.30% on average per year.
EPS Next Y-12.26%
EPS Next 2Y-0.48%
EPS Next 3Y6.43%
EPS Next 5Y4.09%
Revenue Next Year-9.53%
Revenue Next 2Y-3.01%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.3%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 78.52 indicates a quite expensive valuation of AQNB.
  • Compared to the rest of the industry, the Price/Earnings ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 96.15% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.92, AQNB is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 70.70, the valuation of AQNB can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 96.15% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of AQNB to the average of the S&P500 Index (27.78), we can say AQNB is valued expensively.
Industry RankSector Rank
PE 78.52
Fwd PE 70.7
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 96.15% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.75
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.48%
EPS Next 3Y6.43%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.17%, AQNB is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 3.50, AQNB pays a better dividend. On top of this AQNB pays more dividend than 88.46% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, AQNB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.17%

5.2 History

  • The dividend of AQNB has a limited annual growth rate of 0.06%.
  • AQNB has been paying a dividend for over 5 years, so it has already some track record.
  • AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • The earnings of AQNB are negative and hence is the payout ratio. AQNB will probably not be able to sustain this dividend level.
  • AQNB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-569.86%
EPS Next 2Y-0.48%
EPS Next 3Y6.43%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

25.91

+0.1 (+0.39%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07
Earnings (Next)02-26
Inst Owners74.14%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.91B
Revenue(TTM)2.39B
Net Income(TTM)-37.22M
Analysts68.33
Price Target20.21 (-22%)
Short Float %0%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield 4.17%
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-569.86%
Div Incr Years1
Div Non Decr Years4
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.46%
Min EPS beat(2)-0.69%
Max EPS beat(2)35.61%
EPS beat(4)2
Avg EPS beat(4)12.84%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)4
Avg EPS beat(8)5.61%
EPS beat(12)5
Avg EPS beat(12)1.98%
EPS beat(16)6
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)0.82%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-1.75%
Revenue beat(12)6
Avg Revenue beat(12)-0.49%
Revenue beat(16)9
Avg Revenue beat(16)0.59%
PT rev (1m)-3.36%
PT rev (3m)-5.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-26.45%
EPS NY rev (1m)0%
EPS NY rev (3m)3.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.25%
Valuation
Industry RankSector Rank
PE 78.52
Fwd PE 70.7
P/S 8.34
P/FCF N/A
P/OCF 42.74
P/B 4.29
P/tB 6.11
EV/EBITDA 28.75
EPS(TTM)0.33
EY1.27%
EPS(NY)0.37
Fwd EY1.41%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)0.61
OCFY2.34%
SpS3.11
BVpS6.04
TBVpS4.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.7
Profitability
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROCE 4%
ROIC 3.16%
ROICexc 3.18%
ROICexgc 3.56%
OM 21.55%
PM (TTM) N/A
GM 73.94%
FCFM N/A
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexgc growth 3Y4.3%
ROICexgc growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Debt/EBITDA 6.76
Cap/Depr 208.02%
Cap/Sales 34.55%
Interest Coverage 1.49
Cash Conversion 51.11%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.03
Altman-Z 1.32
F-Score4
WACC7.05%
ROIC/WACC0.45
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
EPS Next Y-12.26%
EPS Next 2Y-0.48%
EPS Next 3Y6.43%
EPS Next 5Y4.09%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%
Revenue Next Year-9.53%
Revenue Next 2Y-3.01%
Revenue Next 3Y-0.37%
Revenue Next 5Y2.3%
EBIT growth 1Y-15.87%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year48.7%
EBIT Next 3Y21.37%
EBIT Next 5YN/A
FCF growth 1Y-47.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.45%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%

ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 / AQNB FAQ

Can you provide the ChartMill fundamental rating for ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079?

ChartMill assigns a fundamental rating of 3 / 10 to AQNB.


What is the valuation status of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) stock?

ChartMill assigns a valuation rating of 0 / 10 to ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB). This can be considered as Overvalued.


How profitable is ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) stock?

ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) has a profitability rating of 3 / 10.


How financially healthy is ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079?

The financial health rating of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) is 4 / 10.


Can you provide the dividend sustainability for AQNB stock?

The dividend rating of ALGONQUIN PWR & UTILITY - AQNCN 8.5321 07/01/2079 (AQNB) is 6 / 10 and the dividend payout ratio is -569.86%.